Anal fissure treatment market to reach $2.41 billion by 2030

The Business Research Company says the global anal fissure treatment market will grow from $1.55 billion in 2025 to $1.7 billion in 2026, then to $2.41 billion by 2030. North America led the market in 2025, while Asia-Pacific is expected to grow fastest as demand rises for minimally invasive and home-based care.

Why it matters: - The anal fissure treatment market is expanding as gastrointestinal disorders become more common and patients seek less invasive care. - The market’s growth points to rising demand for topical therapies, stool softeners and outpatient treatment options. - Faster growth in Asia-Pacific could shift future commercial focus beyond North America.

What happened: - The Business Research Company released its Anal Fissure Treatment Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will rise from $1.55 billion in 2025 to $1.7 billion in 2026, a 9.6% compound annual growth rate. - The report forecasts the market will reach $2.41 billion by 2030, with a 9.2% compound annual growth rate from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

The details: - Anal fissure treatment focuses on healing small tears in the tissue lining the anus. - Common treatments include sitz baths and stool softeners, which help relax the anal sphincter muscles, reduce pain and support natural healing. - Recent market growth has been supported by rising prevalence of gastrointestinal disorders, wider use of conservative treatment methods, availability of topical nitroglycerin therapies, greater clinical awareness and stool-softening regimens. - The report says future growth will be driven by demand for minimally invasive treatment options, home-based care, specialized colorectal clinics, combination therapies and long-term symptom management. - Emerging trends include more non-surgical treatment, wider use of topical therapies, earlier diagnosis and management, outpatient protocols and improved patient comfort and adherence. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The report ties market growth to a broader shift toward conservative care and easier-to-use therapies. - The citation of Canada’s inflammatory bowel disease data shows how digestive disease prevalence can feed demand for fissure treatment. - In September 2023, the National Library of Medicine reported Canada’s IBD incidence rate at 30 cases per 100,000 in 2023, with about 11,000 new diagnoses. - The National Library of Medicine projected that rate would rise 0.58% annually to 32.1 per 100,000 by 2035.

What’s next: - The report expects continued demand for non-surgical care and combination therapies through 2030. - Market growth will likely track the expansion of outpatient protocols, early diagnosis efforts and home-based treatment preferences. - The Asia-Pacific region remains the key upside market if forecast trends hold.

The bottom line: - Anal fissure treatment is moving toward less invasive, more accessible care, and the market is expected to keep growing steadily through 2030.